A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

BACKGROUND: Astodrimer Gel contains a novel dendrimer intended to treat and prevent bacterial vaginosis. We assessed the efficacy and safety of Astodrimer Gel for treatment of bacterial vaginosis. METHODS: 132 women with bacterial vaginosis were randomized 1:1:1:1 to Astodrimer 0.5% (N = 34), 1% (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Waldbaum, Arthur S., Schwebke, Jane R., Paull, Jeremy R. A., Price, Clare F., Edmondson, Stephanie R., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197797/
https://www.ncbi.nlm.nih.gov/pubmed/32365097
http://dx.doi.org/10.1371/journal.pone.0232394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197797/
https://www.ncbi.nlm.nih.gov/pubmed/32365097
http://dx.doi.org/10.1371/journal.pone.0232394

Ejemplares similares